By targeting STAT3, Lip-FLLL32 inhibits both proliferating pancreatic cancer cells and pancreatic cancer stem cells, resulting in reversal of radioresistance induced by CSCs (Figure 7B–7C). Here, STAT3 is linked to familial pancreatic carcinoma.